Literature DB >> 16313492

Melatonin as a cytoskeletal modulator: implications for cell physiology and disease.

Gloria Benítez-King1.   

Abstract

The cytoskeleton is a phylogenetically well-preserved structure that plays a key role in cell physiology. Dynamic and differential changes in cytoskeletal organization occur in cellular processes according to the cell type and the specific function. In neurons, microtubules, microfilaments and intermediate filament (IF) rearrangements occur during axogenesis, and neurite formation which eventually differentiate into axons and dendrites to constitute synaptic patterns of connectivity. In epithelial cells, dynamic modifications occur in the three main cytoskeletal components and phosphorylation of cytoskeletal associated proteins takes place during the formation of the epithelial cell monolayer that eventually will transport water. In pathological processes such as neurodegenerative and psychiatric diseases an abnormal cytoskeletal organization occurs. Melatonin, the main product secreted by pineal gland during dark phase of the photoperiod, is capable of influencing microfilament, microtubule and IF organization by acting as a cytoskeletal modulator. In this paper we will summarize the evidence which provides the data that melatonin regulates cytoskeletal organization and we describe recent findings, which indicate that melatonin effects on microfilament rearrangements in stress fibers are involved in the mechanism by which the indole synchronizes water transport in kidney-derived epithelial cells. In addition, we review recent data, which indicates that melatonin protects the neuro-cytoskeletal organization from damage caused by free radicals contributing to cell survival, in addition to the already described mechanism elicited by the indole to prevent apoptosis and to scavenge free radicals. Moreover, we discuss the implications of an altered cytoskeletal organization for neurodegenerative and psychiatric illnesses and its re-establishment by melatonin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16313492     DOI: 10.1111/j.1600-079X.2005.00282.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  34 in total

1.  Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection.

Authors:  Venkatramanujam Srinivasan; Daniel P Cardinali; Uddanapalli S Srinivasan; Charanjit Kaur; Gregory M Brown; D Warren Spence; Rüdiger Hardeland; Seithikurippu R Pandi-Perumal
Journal:  Ther Adv Neurol Disord       Date:  2011-09       Impact factor: 6.570

Review 2.  Melatonin therapy for REM sleep behavior disorder: a critical review of evidence.

Authors:  Ian R McGrane; Jonathan G Leung; Erik K St Louis; Bradley F Boeve
Journal:  Sleep Med       Date:  2014-10-13       Impact factor: 3.492

3.  Melatonin: neuritogenesis and neuroprotective effects in crustacean x-organ cells.

Authors:  Gregory A Cary; Anne S Cuttler; Kirsten A Duda; Escar T Kusema; Jennifer A Myers; Andrea R Tilden
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2011-12-16       Impact factor: 2.320

4.  Melatonin activates the vascular elements, telocytes, and neuroimmune communication in the adrenal gland of Soay rams during the non-breeding season.

Authors:  Manal T Hussein; Doaa M Mokhtar; A H S Hassan
Journal:  Protoplasma       Date:  2019-10-22       Impact factor: 3.356

Review 5.  Distribution, function and physiological role of melatonin in the lower gut.

Authors:  Chun-Qiu Chen; Jakub Fichna; Mohammad Bashashati; Yong-Yu Li; Martin Storr
Journal:  World J Gastroenterol       Date:  2011-09-14       Impact factor: 5.742

Review 6.  Molecular mechanisms of melatonin's inhibitory actions on breast cancers.

Authors:  Sara Proietti; Alessandra Cucina; Russel J Reiter; Mariano Bizzarri
Journal:  Cell Mol Life Sci       Date:  2012-09-25       Impact factor: 9.261

7.  Immunomodulatory effect of melatonin in SK-LU-1 human lung adenocarcinoma cells co-cultured with peripheral blood mononuclear cells.

Authors:  P Plaimee; M Khamphio; N Weerapreeyakul; S Barusrux; N P Johns
Journal:  Cell Prolif       Date:  2014-07-23       Impact factor: 6.831

Review 8.  Immune-pineal axis - acute inflammatory responses coordinate melatonin synthesis by pinealocytes and phagocytes.

Authors:  Regina P Markus; Pedro A Fernandes; Gabriela S Kinker; Sanseray da Silveira Cruz-Machado; Marina Marçola
Journal:  Br J Pharmacol       Date:  2017-12-15       Impact factor: 8.739

9.  Therapeutic effect of melatonin in experimental uveitis.

Authors:  Pablo Horacio Sande; Diego Carlos Fernandez; Hernán Javier Aldana Marcos; Mónica Silvia Chianelli; Julieta Aisemberg; Dafne Magalí Silberman; Daniel Alberto Sáenz; Ruth Estela Rosenstein
Journal:  Am J Pathol       Date:  2008-11-13       Impact factor: 4.307

Review 10.  Anti-Inflammatory Effects of Melatonin in Obesity and Hypertension.

Authors:  Natalia Jorgelina Prado; León Ferder; Walter Manucha; Emiliano Raúl Diez
Journal:  Curr Hypertens Rep       Date:  2018-05-09       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.